HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes
Open Access
- 10 July 2012
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 9 (7) , e1001258
Abstract
Until now, decisions about how to allocate ART have largely been based on maximising the therapeutic benefit of ART for patients. Since the results of the HPTN 052 study showed efficacy of antiretroviral therapy (ART) in preventing HIV transmission, there has been increased interest in the benefits of ART not only as treatment, but also in prevention. Resources for expanding ART in the short term may be limited, so the question is how to generate the most prevention benefit from realistic potential increases in the availability of ART. Although not a formal systematic review, here we review different ways in which access to ART could be expanded by prioritising access to particular groups based on clinical or behavioural factors. For each group we consider (i) the clinical and epidemiological benefits, (ii) the potential feasibility, acceptability, and equity, and (iii) the affordability and cost-effectiveness of prioritising ART access for that group. In re-evaluating the allocation of ART in light of the new data about ART preventing transmission, the goal should be to create policies that maximise epidemiological and clinical benefit while still being feasible, affordable, acceptable, and equitable.Keywords
This publication has 108 references indexed in Scilit:
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Extended high viremicsAIDS, 2011
- HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapyAIDS, 2011
- Advances in developing HIV-1 viral load assays for resource-limited settingsBiotechnology Advances, 2010
- Antiretroviral therapy for tuberculosis control in nine African countriesProceedings of the National Academy of Sciences, 2010
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysisThe Lancet, 2010
- HIV Infection–Related Tuberculosis: Clinical Manifestations and TreatmentClinical Infectious Diseases, 2010
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis TherapyNew England Journal of Medicine, 2010
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesThe Lancet, 2009
- Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesisProceedings of the National Academy of Sciences, 2007